NEW YORK, March 14, 2014 /PRNewswire/ --
Today, Analysts Review released its analysts' notes regarding
The Blackstone Group (NYSE: BX), CIT Group Inc. (NYSE: CIT), CME
Group Inc. (NASDAQ: CME), TD Ameritrade Holding Corporation (NYSE:
AMTD), and General Growth Properties Inc. (NYSE: GGP). Private
wealth members receive these notes ahead of publication. To reserve
complementary membership, limited openings are available at:
http://www.AnalystsReview.com/register
The Blackstone Group Analyst Notes
On March 11, 2014, The Blackstone
Group (Blackstone) announced that a fund the Company manages on
behalf of its private equity investors has entered into a
definitive agreement to acquire a majority stake in Accuvant Inc.
(Accuvant). According to Blackstone, Accuvant management and
existing shareholders Sverica International LLC will invest
alongside the Company in the transaction. Commenting on the
release, Dave Johnson, Senior
Managing Director in Blackstone's Private Equity Group, stated,
"With this investment, we are excited to build upon Blackstone's
growing information security expertise as the sector becomes
increasingly relevant across industries. Our investment will
provide Accuvant's experienced team with necessary resources as it
continues to establish a reputation for excellence in the
information risk and security space." The full analyst notes on The
Blackstone Group are available to download free of charge at:
http://www.AnalystsReview.com/03142014/BX/report.pdf
CIT Group Inc. Analyst Notes
On March 11, 2014, CIT Group Inc.
(CIT) announced that CIT Aerospace has raised more than
$75,000 to support the Miami
Children's Hospital LifeFlight® program during its inaugural CIT
Aerospace Golf Invitational held at the Diplomat Tennis and Golf
Club. Jeff Knittel, President of CIT
Transportation and International Finance, stated, "We are very
pleased with the success of the inaugural CIT Aerospace Golf
Invitational, which raised much needed funds and created greater
awareness of LifeFlight and its important mission." The full
analyst notes on CIT Group Inc. are available to download free of
charge at:
http://www.AnalystsReview.com/03142014/CIT/report.pdf
CME Group Inc. Analyst Notes
On March 11, 2014, CME Group Inc.
(CME Group) announced that it has received approval from the UK's
Financial Conduct Authority (FCA) for a London-based derivatives exchange. According
to the release, CME Europe Ltd will be a Recognized Investment
Exchange and will launch on April 27,
2014. Additionally, the CME Group stated that the exchange
has received approval to list its first commodity products, along
with releasing the previously announced plan of launching a full
suite of FX futures products on the same day, subject to final
regulatory approval of certain operational clearing conditions.
Commenting on the release, Terry
Duffy, CME Group Executive Chairman and President, stated,
"Our European customers are increasingly looking for ways to manage
risk and access liquidity in a local jurisdiction. CME Europe now
allows us to better serve our customers in the region as we expand
our business with relevant products. In addition, the combined move
to central clearing and London
serving as the center of global foreign exchange trading will mean
our new exchange is well positioned to serve all of Europe." The full analyst notes on CME Group
Inc. are available to download free of charge at:
http://www.AnalystsReview.com/03142014/CME/report.pdf
TD Ameritrade Holding Corporation
Analyst Notes
On March 11, 2014, TD Ameritrade
Holding Corporation (TD Ameritrade) announced that it has reached a
monthly average client trades per day eclipsing 500,000 for the
first time in the Company's history. According to the release,
average client trades per day for February
2014 were a record 501,000, an increase of 1% compared to
the record 496,000 average trades per day reported for January 2014. Commenting on the release,
Fred Tomczyk, President and CEO of
the Company, stated, "We have reached an important milestone at TD
Ameritrade: half-a-million average trades per day for the month of
February. Investors remain engaged, and their behavior continues to
suggest a bullish outlook moving forward. Investments in our
systems, trading tools and education, have helped us respond to our
clients' needs in this market and will remain a focus for us as we
seek to sustain engagement and continue growing our market share."
The full analyst notes on TD Ameritrade Holding Corporation are
available to download free of charge at:
http://www.AnalystsReview.com/03142014/AMTD/report.pdf
General Growth Properties Inc. Analyst
Notes
On March 11, 2014, General Growth
Properties Inc.'s (GGP) stock went up by 0.36%, closing at
$22.08 per share. Over the past
five-day trading period, the Company's stock declined by 1.52%,
compared to the Dow Jones Industrial Average which went up by 0.27%
during the same trading period. The full analyst notes on General
Growth Properties Inc. are available to download free of charge
at:
http://www.AnalystsReview.com/03142014/GGP/report.pdf
About Analysts Review
We provide our members with a simple and reliable way to
leverage our economy of scale. Most investors do not have time to
track all publicly traded companies, much less perform an in-depth
review and analysis of the complexities contained in each
situation. That's where Analysts Review comes in. We provide a
single unified platform for investors' to hear about what matters.
Situation alerts, moving events, and upcoming opportunities.
=============
EDITOR NOTES:
- This is not company news. We are an independent source and our
views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a
best efforts basis and reviewed by Nidhi Vatsal, a CFA
charterholder. However, we are only human and are prone to make
mistakes. If you notice any errors or omissions, please notify us
below.
- This information is submitted as a net-positive to companies
mentioned, to increase awareness for mentioned companies to our
subscriber base and the investing public.
- If you wish to have your company covered in more detail by our
team, or wish to learn more about our services, please contact us
at pubco [at] AnalystsReview.com.
- For any urgent concerns or inquiries, please contact us
at compliance [at] AnalystsReview.com.
- Are you a public company? Would you like to see similar
coverage on your company? Send us a full investors' package to
research [at] AnalystsReview.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort
basis. This document, article or report is prepared and authored by
Analysts Review. An outsourced research services provider
represented by Nidhi Vatsal, CFA, has only reviewed the information
provided by Analysts Review in this article or report according to
the Procedures outlined by Analysts Review. Analysts Review is not
entitled to veto or interfere in the application of such procedures
by the outsourced provider to the articles, documents or reports,
as the case may be.
NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to
the accuracy or completeness or fitness for a purpose (investment
or otherwise), of the information provided in this document. This
information is not to be construed as personal financial advice.
Readers are encouraged to consult their personal financial advisor
before making any decisions to buy, sell or hold any securities
mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be
occasioned at the time of printing of this document or any error,
mistake or shortcoming. No liability is accepted by Analysts Review
whatsoever for any direct, indirect or consequential loss arising
from the use of this document. Analysts Review expressly disclaims
any fiduciary responsibility or liability for any consequences,
financial or otherwise arising from any reliance placed on the
information in this document. Analysts Review does not (1)
guarantee the accuracy, timeliness, completeness or correct
sequencing of the information, or (2) warrant any results from use
of the information. The included information is subject to change
without notice.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
http://www.AnalystsReview.com
SOURCE Analysts Review